» Articles » PMID: 37317257

-An Emerging Old Entity?

Overview
Journal Microorganisms
Specialty Microbiology
Date 2023 Jun 15
PMID 37317257
Authors
Affiliations
Soon will be listed here.
Abstract

is an evasive pathogen that can prompt severe clinical manifestations in humans such as vaginitis, epididymitis, lymphogranuloma venereum, trachoma, conjunctivitis and pneumonia. If left untreated, chronic infections with can give rise to long-lasting and even permanent sequelae. To shed some light on its widespread nature, data from original research, systematic reviews and meta-analyses from three databases was collected and analyzed in the context of chlamydial infection, related symptoms and appropriate treatment modalities. This review describes the bacterium's pervasiveness on a global scale, especially in developing countries, and suggests ways to halt its transmission and spread. Infections with often go unnoticed, as many individuals are asymptomatic and unaware of their diagnosis, contributing to a delay in diagnosis and treatment. The high prevalence of chlamydial infection highlights the need for a universal screening and detection method enabling immediate treatment at its onset. Prognosis is favorable with antibiotic therapy and education for high-risk groups and their sexual partners. In the future, a quick, easily accessible, and inexpensive test should be developed to diagnose and treat infected individuals early on. Along with a vaccine against , it would halt the transmission and spread of the pathogen worldwide.

Citing Articles

: From Urogenital Infections to the Pathway of Infertility.

Rodrigues R, Sousa C, Barros A, Vale N Genes (Basel). 2025; 16(2).

PMID: 40004534 PMC: 11855039. DOI: 10.3390/genes16020205.


Profile of vaccine research: A bibliometric analysis.

Wang X, Wang Q, Gao Y, Jiang L, Tang L Hum Vaccin Immunother. 2025; 21(1):2459459.

PMID: 39906958 PMC: 11801346. DOI: 10.1080/21645515.2025.2459459.


Conjugated therapeutic proteins as a treatment for bacteria which trigger cancer development.

Halawa M, Newman P, Aderibigbe T, Carabetta V iScience. 2024; 27(10):111029.

PMID: 39635133 PMC: 11615139. DOI: 10.1016/j.isci.2024.111029.


HPV and HCMV in Cervical Cancer: A Review of Their Co-Occurrence in Premalignant and Malignant Lesions.

Blanco R, Munoz J Viruses. 2024; 16(11).

PMID: 39599814 PMC: 11599080. DOI: 10.3390/v16111699.


Cell-Free Screening, Production and Animal Testing of a STI-Related Chlamydial Major Outer Membrane Protein Supported in Nanolipoproteins.

Mohagheghi M, Abisoye-Ogunniyan A, Evans A, Peterson A, Bude G, Hoang-Phou S Vaccines (Basel). 2024; 12(11).

PMID: 39591149 PMC: 11598365. DOI: 10.3390/vaccines12111246.


References
1.
Becker E, Hegemann J . All subtypes of the Pmp adhesin family are implicated in chlamydial virulence and show species-specific function. Microbiologyopen. 2014; 3(4):544-56. PMC: 4287181. DOI: 10.1002/mbo3.186. View

2.
Hueck C . Type III protein secretion systems in bacterial pathogens of animals and plants. Microbiol Mol Biol Rev. 1998; 62(2):379-433. PMC: 98920. DOI: 10.1128/MMBR.62.2.379-433.1998. View

3.
Mestecky J, Raska M, Novak J, Alexander R, Moldoveanu Z . Antibody-mediated protection and the mucosal immune system of the genital tract: relevance to vaccine design. J Reprod Immunol. 2010; 85(1):81-5. PMC: 2885831. DOI: 10.1016/j.jri.2010.02.003. View

4.
Mabey D, Peeling R . Lymphogranuloma venereum. Sex Transm Infect. 2002; 78(2):90-2. PMC: 1744436. DOI: 10.1136/sti.78.2.90. View

5.
Bebear C, De Barbeyrac B . Genital Chlamydia trachomatis infections. Clin Microbiol Infect. 2009; 15(1):4-10. DOI: 10.1111/j.1469-0691.2008.02647.x. View